Financhill
Back

MediWound Quote, Financials, Valuation and Earnings

MediWound Price Quote

$17.24
+0.11 (+0.64%)
(Updated: December 11, 2024 at 5:55 PM ET)

MediWound Key Stats

Buy
58
MediWound (MDWD) is a Buy

Day range:
$16.70 - $17.36
52-week range:
$9.91 - $24.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.31
P/B ratio:
5.4%

Volume:
44.9K
Avg. volume:
53.5K
1-year change:
75.51%
Market cap:
$184.8M
Revenue:
$18.7M
EPS:
$-2.9

How Much Does MediWound Make?

  • How Much Are MediWound's Sales Annually?
    MDWD Revenues are $18.7M
  • How Much Profit Does MediWound's Make A Year?
    MDWD net income is -$6.7M

Is MediWound Growing As A Company?

  • What Is MediWound's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.09%
  • What Is MediWound's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

MediWound Stock Price Performance

  • Did MediWound Stock Go Up Last Month?
    MediWound share price went down by -0.9% last month
  • Did MDWD's Share Price Rise Over The Last Year?
    MDWD share price rose by 75.51% over the past 1 year

What Is MediWound 52-Week High & Low?

  • What Is MediWound’s 52-Week High Share Price?
    MediWound has traded as high as $24.00 over the past 52 weeks
  • What Is MediWound’s 52-Week Low Share Price?
    MediWound has traded as low as $9.91 over the past 52 weeks

MediWound Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy MediWound?

  • How Much Debt Does MediWound Have?
    Total long term debt quarterly is $0
  • How Much Cash Does MediWound Have?
    Cash and short term investments quarterly total is $45.6M
  • What Is MediWound’s Book Value Per Share?
    Book value per share is 3.17

Is MediWound Cash Flow Positive?

  • What Is MDWD Cash Flow From Operations?
    Cash flow from operations (TTM) is -$14.6M
  • What Is MediWound’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $19.7M
  • What Is MediWound’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$8.2M

MediWound Return On Invested Capital

  • Is Management Doing A Good Job?
    MDWD return on invested capital is -100.25%
  • What Is MediWound Return On Assets?
    ROA measures how assets are converting to revenues and is -42.79%
  • What Is MDWD Return On Equity?
    ROE is a measure of profitability and is -100.25%

MediWound Earnings Date & Stock Price

  • What Is MediWound's Stock Price Today?
    A single share of MDWD can be purchased today for 17.13
  • What Is MediWound’s Stock Symbol?
    MediWound trades on the nasdaq under the ticker symbol: MDWD
  • When Is MediWound’s Next Earnings Date?
    The next quarterly earnings date for MediWound is scheduled on March 21, 2025
  • When Is MDWD's next ex-dividend date?
    MediWound's next ex-dividend date is May 12, 2020
  • How To Buy MediWound Stock?
    You can buy MediWound shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

MediWound Competitors

  • Who Are MediWound's Competitors?
    Below is a list of companies who compete with MediWound or are related in some way:
    • BioLine Rx Ltd (BLRX)
    • Can Fite Biofarma Ltd (CANF)
    • Compugen Ltd (CGEN)
    • BiomX Inc (PHGE)
    • Pluri Inc (PLUR)

MediWound Dividend Yield

  • What Is MDWD Dividend Yield?
    MediWound’s dividend yield currently is 0%
  • What Is MediWound’s Payout Ratio?
    MediWound’s payout ratio is 0%
  • When Did MediWound Last Pay A Dividend?
    The latest dividend pay date is December 12, 2024
  • What Is MediWound’s Dividend Per Share?
    MediWound pays a dividend of $0.00 per share

MediWound Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -121.05%
Revenue: -8.82% -27.5%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 29.00
Upside from Last Price: 69.29%

Major Shareholders

  • How many MDWD shares are owned by institutional investors?
    6.7M MDWD shares are owned by institutional investors
  • How many MDWD shares are owned by insiders?
    0 MDWD shares are owned by insiders